Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cote

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Urologic Oncology|August 22, 2025
Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapyC N Sternberg, P Squifflet, E D Saad, et al.
Blood|July 10, 1998
Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantationF Garcia-Sanchez, G Pizzorno, S Q Fu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 1996
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapyE G Hanania, R E Giles, J Kavanagh, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Urologic Oncology|August 22, 2025
Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapyC N Sternberg, P Squifflet, E D Saad, et al.
Blood|July 10, 1998
Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantationF Garcia-Sanchez, G Pizzorno, S Q Fu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 1996
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapyE G Hanania, R E Giles, J Kavanagh, et al.
Pageof 10